SEARCH

SEARCH BY CITATION

References

  • 1
    Landis SH,Murray T,Bolden S,Wingo PA. Cancer statistics, 1999. CA Cancer J Clin 1999; 49: 831.
  • 2
    Bubendorf L,Schopfer A,Wagner U,Sauter G,Moch H,Willi N,Gasser TC,Mihatsch MJ. Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients. Hum Pathol 2000; 31: 57883.
  • 3
    Berruti A,Piovesan A,Torta M,Raucci CA,Gorzegno G,Paccotti P,Dogliotti L,Angeli A. Biochemical evaluation of bone turnover in cancer patients with bone metastases: relationship with radiograph appearances and disease extension. Br J Cancer 1996; 73: 15817.
  • 4
    Urwin GH,Percival RC,Harris S,Beneton MN,Williams JL,Kanis JA. Generalised increase in bone resorption in carcinoma of the prostate. Br J Urol 1985; 57: 7213.
  • 5
    Vinholes J,Coleman R,Eastell R. Effects of bone metastases on bone metabolism: implications for diagnosis, imaging and assessment of response to cancer treatment. Cancer Treat Rev 1996; 22: 289331.
  • 6
    Roudier MP,True LD,Higano CS,Vesselle H,Ellis W,Lange P,Vessella RL. Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. Hum Pathol 2003; 34: 64653.
  • 7
    Roodman GD. Mechanisms of bone metastasis. N Engl J Med 2004; 350: 165564.
  • 8
    Aiuti A,Tavian M,Cipponi A,Ficara F,Zappone E,Hoxie J,Peault B,Bordignon C. Expression of CXCR4, the receptor for stromal cell-derived factor-1 on fetal and adult human lympho-hematopoietic progenitors. Eur J Immunol 1999; 29: 182331.
  • 9
    Kim CH,Broxmeyer HE. SLC/exodus2/6Ckine/TCA4 induces chemotaxis of hematopoietic progenitor cells: differential activity of ligands of CCR7, CXCR3, or CXCR4 in chemotaxis vs. suppression of progenitor proliferation. J Leukoc Biol 1999; 66: 45561.
  • 10
    Russell HV,Hicks J,Okcu MF,Nuchtern JG. CXCR4 expression in neuroblastoma primary tumors is associated with clinical presentation of bone and bone marrow metastases. J Pediatr Surg 2004; 39: 150611.
  • 11
    Darash-Yahana M,Pikarsky E,Abramovitch R,Zeira E,Pal B,Karplus R,Beider K,Avniel S,Kasem S,Galun E,Peled A. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis. FASEB J 2004; 18: 12402.
  • 12
    Geminder H,Sagi-Assif O,Goldberg L,Meshel T,Rechavi G,Witz IP,Ben-Baruch A. A possible role for CXCR4 and its ligand, the CXC chemokine stromal cell-derived factor-1, in the development of bone marrow metastases in neuroblastoma. J Immunol 2001; 167: 474757.
  • 13
    Kozlow W,Guise TA. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 2005; 10: 16980.
  • 14
    Mochizuki H,Matsubara A,Teishima J,Mutaguchi K,Yasumoto H,Dahiya R,Usui T,Kamiya K. Interaction of ligand-receptor system between stromal-cell-derived factor-1 and CXC chemokine receptor 4 in human prostate cancer: a possible predictor of metastasis. Biochem Biophys Res Commun 2004; 320: 65663.
  • 15
    Taichman RS,Cooper C,Keller ET,Pienta KJ,Taichman NS,McCauley LK. Use of the stromal cell-derived factor-1/CXCR4 pathway in prostate cancer metastasis to bone. Cancer Res 2002; 62: 18327.
  • 16
    Sun YX,Schneider A,Jung Y,Wang J,Dai J,Wang J,Cook K,Osman NI,Koh-Paige AJ,Shim H,Pienta KJ,Keller ET, et al. Skeletal localization and neutralization of the SDF-1(CXCL12)/CXCR4 axis blocks prostate cancer metastasis and growth in osseous sites in vivo. J Bone Miner Res 2005; 20: 31829.
  • 17
    Zhu JF,Valente AJ,Lorenzo JA,Carnes D,Graves DT. Expression of monocyte chemoattractant protein 1 in human osteoblastic cells stimulated by proinflammatory mediators. J Bone Miner Res 1994; 9: 112330.
  • 18
    Lu Y,Cai Z,Galson DL,Xiao G,Liu Y,George DE,Melhem MF,Yao Z,Zhang J. Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion. Prostate 2006; 66: 131118.
  • 19
    Nam JS,Kang MJ,Suchar AM,Shimamura T,Kohn EA,Michalowska AM,Jordan VC,Hirohashi S,Wakefield LM. Chemokine (C-C motif) ligand 2 mediates the prometastatic effect of dysadherin in human breast cancer cells. Cancer Res 2006; 66: 717684.
  • 20
    Vande Broek I,Asosingh K,Vanderkerken K,Straetmans N,Van Camp B,Van Riet I. Chemokine receptor CCR2 is expressed by human multiple myeloma cells and mediates migration to bone marrow stromal cell-produced monocyte chemotactic proteins MCP-1, -2 and -3. Br J Cancer 2003; 88: 85562.
  • 21
    Loberg RD,Day LL,Harwood J,Ying C,St John LN,Giles R,Neeley CK,Pienta KJ. CCL2 is a potent regulator of prostate cancer cell migration and proliferation. Neoplasia 2006; 8: 57886.
  • 22
    Graves DT,Jiang Y,Valente AJ. Regulated expression of MCP-1 by osteoblastic cells in vitro and in vivo. Histol Histopathol 1999; 14: 134754.
  • 23
    Van Damme J,Decock B,Lenaerts JP,Conings R,Bertini R,Mantovani A,Billiau A. Identification by sequence analysis of chemotactic factors for monocytes produced by normal and transformed cells stimulated with virus, double-stranded RNA or cytokine. Eur J Immunol 1989; 19: 236773.
  • 24
    Stifter S. The role of nuclear factor κB on angiogenesis regulation through monocyte chemotactic protein-1 in myeloma. Med Hypotheses 2006; 66: 3846.
  • 25
    Hurwitz AA,Lyman WD,Berman JW. Tumor necrosis factor α and transforming growth factor β upregulate astrocyte expression of monocyte chemoattractant protein-1. J Neuroimmunol 1995; 57: 1938.
  • 26
    Johrer K,Janke K,Krugmann J,Fiegl M,Greil R. Transendothelial migration of myeloma cells is increased by tumor necrosis factor (TNF)-α via TNF receptor 2 and autocrine up-regulation of MCP-1. Clin Cancer Res 2004; 10: 190110.
  • 27
    Kim MS DC,Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-{κ}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 2005; 280: 161639.
  • 28
    Juppner H,Abou-Samra AB,Freeman M,Kong XF,Schipani E,Richards J,Kolakowski LF,Hock J,Potts JT,Kronenberg HM. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 1991; 254: 10246.
  • 29
    Burtis WJ. Parathyroid hormone-related protein: structure, function, and measurement. Clin Chem 1992; 38: 217183.
  • 30
    Uy HL,Guise TA,De La Mata J,Taylor SD,Story BM,Dallas MR,Boyce BF,Mundy GR,Roodman GD. Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo. Endocrinology 1995; 136: 320712.
  • 31
    Dougherty KM,Blomme EA,Koh AJ,Henderson JE,Pienta KJ,Rosol TJ,McCauley LK. Parathyroid hormone-related protein as a growth regulator of prostate carcinoma. Cancer Res 1999; 59: 601522.
  • 32
    Iwamura M,di Sant'Agnese PA,Wu G,Benning CM,Cockett AT,Deftos LJ,Abrahamsson PA. Immunohistochemical localization of parathyroid hormone-related protein in human prostate cancer. Cancer Res 1993; 53: 17246.
  • 33
    Iwamura M,Gershagen S,Lapets O,Moynes R,Abrahamsson PA,Cockett AT,Deftos LJ,di Sant'Agnese PA. Immunohistochemical localization of parathyroid hormone-related protein in prostatic intraepithelial neoplasia. Hum Pathol 1995; 26: 797801.
  • 34
    Iwamura M,Abrahamsson PA,Foss KA,Wu G,Cockett AT,Deftos LJ. Parathyroid hormone-related protein: a potential autocrine growth regulator in human prostate cancer cell lines. Urology 1994; 43: 6759.
  • 35
    Deftos LJ,Barken I,Burton DW,Hoffman RM,Geller J. Direct evidence that PTHrP expression promotes prostate cancer progression in bone. Biochem Biophys Res Commun 2005; 327: 46872.
  • 36
    Guise TA,Yin JJ,Thomas RJ,Dallas M,Cui Y,Gillespie MT. Parathyroid hormone-related protein (PTHrP)-(1–139) isoform is efficiently secreted in vitro and enhances breast cancer metastasis to bone in vivo. Bone 2002; 30: 6706.
  • 37
    Yin JJ,Selander K,Chirgwin JM,Dallas M,Grubbs BG,Wieser R,Massague J,Mundy GR,Guise TA. TGF-β signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. J Clin Invest 1999; 103: 197206.
  • 38
    Dunbar ME,Wysolmerski JJ. Parathyroid hormone-related protein: a developmental regulatory molecule necessary for mammary gland development. J Mammary Gland Biol Neoplasia 1999; 4: 2134.
  • 39
    Bouizar Z,Spyratos F,De vernejoul MC. The parathyroid hormone-related protein (PTHrP) gene: use of downstream TATA promotor and PTHrP 1–139 coding pathways in primary breast cancers vary with the occurrence of bone metastasis. J Bone Miner Res 1999; 14: 40614.
  • 40
    Sekine O,Nishio Y,Egawa K,Nakamura T,Maegawa H,Kashiwagi A. Insulin activates CCAAT/enhancer binding proteins and proinflammatory gene expression through the phosphatidylinositol 3-kinase pathway in vascular smooth muscle cells. J Biol Chem 2002; 277: 366319.
  • 41
    Ueda A,Ishigatsubo Y,Okubo T,Yoshimura T. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-κB sites and NF-κB/Rel subunit specificity. J Biol Chem 1997; 272: 310929.
  • 42
    Ueda A,Okuda K,Ohno S,Shirai A,Igarashi T,Matsunaga K,Fukushima J,Kawamoto S,Ishigatsubo Y,Okubo T. NF-κB and Sp1 regulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 1994; 153: 205263.
  • 43
    Wang Y,Rangan GK,Goodwin B,Tay YC,Harris DC. Lipopolysaccharide-induced MCP-1 gene expression in rat tubular epithelial cells is nuclear factor-κB dependent. Kidney Int 2000; 57: 201122.
  • 44
    Martin-Ventura JL,Ortego M,Esbrit P,Hernandez-Presa MA,Ortega L,Egido J. Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 2003; 34: 17839.
  • 45
    Hu HM,Tian Q,Baer M,Spooner CJ,Williams SC,Johnson PF,Schwartz RC. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 2000; 275: 1637381.
  • 46
    Kodama K,Nishio Y,Sekine O,Sato Y,Egawa K,Maegawa H,Kashiwagi A. Bidirectional regulation of monocyte chemoattractant protein-1 gene at distinct sites of its promoter by nitric oxide in vascular smooth muscle cells. Am J Physiol Cell Physiol 2005; 289: C582C590.
  • 47
    Ping D,Boekhoudt G,Zhang F,Morris A,Philipsen S,Warren ST,Boss JM. Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene by tumor necrosis factor. J Biol Chem 2000; 275: 170814.
  • 48
    Kim MS,Day CJ,Morrison NA. MCP-1 is induced by receptor activator of nuclear factor-{κ}B ligand, promotes human osteoclast fusion, and rescues granulocyte macrophage colony-stimulating factor suppression of osteoclast formation. J Biol Chem 2005; 280: 161639.
  • 49
    Kim MS,Day CJ,Selinger CI,Magno CL,Stephens SR,Morrison NA. MCP-1-induced human osteoclast-like cells are tartrate-resistant acid phosphatase, NFATc1, and calcitonin receptor-positive but require receptor activator of NFκB ligand for bone resorption. J Biol Chem 2006; 281: 127485.
  • 50
    Saito H,Tsunenari T,Onuma E,Sato K,Ogata E,Yamada-Okabe H. Humanized monoclonal antibody against parathyroid hormone-related protein suppresses osteolytic bone metastasis of human breast cancer cells derived from MDA-MB-231. Anticancer Res 2005; 25: 381723.